CCND1 is an influential cell-cycle regulatory protein, and its overexpression is connected with cell proliferation, poor prognosis and recurrence in breast cancer, which has here shown to be downregulated as an effect of the arsenate exposure. The gene discussed is RCC1; the disease is breast carcinoma.